focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 75.60
Ask: 76.00
Change: -0.50 (-0.65%)
Spread: 0.40 (0.529%)
Open: 76.70
High: 77.00
Low: 75.50
Prev. Close: 76.50
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Termination of Discussions with RMII

6 Sep 2023 07:00

RNS Number : 4669L
GCP Infrastructure Investments Ltd
06 September 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

6 September 2023

GCP Infrastructure Investments Limited

("GCP Infra" or the "Company")

LEI: 213800W64MNATSIV5Z47

Termination of Discussions with RMII

In the Company's announcement on 11 August 2023, the Board of GCP Infra announced that it was in discussions with the Board of RM Infrastructure Income plc ("RMII") regarding a potential combination (the "RM Scheme").

The Board of GCP Infra has been unable to agree on structure and terms with RMII in respect of the RM Scheme that are acceptable to both parties. GCP Infra has therefore notified RMII of the termination of discussions relating to the RM Scheme.

As per its announcement on 11 August, GCP Infra remains in discussions with the board of GCP Asset Backed Income Fund Limited ("GABI") in respect of a proposed combination of GCP Infra with GABI (the "GABI Scheme"). Heads of Terms have been agreed and a shareholder feedback exercise is being conducted. A circular to shareholders of the Company, providing further details of the Proposals and convening a general meeting to approve the Investment Policy Change, alongside a prospectus, is expected to be published in due course.

For further information please contact:

Gravis Capital Management Limited

Philip Kent

Ed Simpson

Cameron Gardner

 

+44 (0)20 3405 8500

Stifel Nicolaus Europe Limited (Sponsor, Financial Adviser and Broker)

Edward Gibson-Watt

Jonathan Wilkes-Green

Catriona Neville

 

 

+44 (0)20 7710 7600

Buchanan

Helen Tarbet

Henry Wilson

George Beale

 

 

+44 (0)20 7466 5000

Important Information

This announcement contains statements about the Company that are or may be deemed to be forward looking statements. Without limitation, any statements preceded or followed by or that includes the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or words or terms of similar substance of the negative thereof, may be forward looking statements.

 

These forward looking statements are not guarantees of future performance. Such forward looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statement. Due to such uncertainties and risks, readers should not rely on such forward looking statements, which speak only as of the date of this announcement, except as required by applicable law.

 

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities laws of such jurisdictions.

 

Market Abuse Regulation

The information contained within this announcement would have, prior to its release, constituted inside information as stipulated under Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019 ("UK MAR"). Upon the publication of this announcement via a regulatory information service, this inside information will be considered to be in the public domain.

 

For the purposes of UK MAR, the person responsible for making this announcement is Satty Grewal-Carter, Manager at Apex Financial Services (Alternative Funds) Limited.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSWFMIEDSEDU
Date   Source Headline
8th Jun 20219:47 amRNSAdditional Listing and Total Voting Rights
28th May 20219:23 amRNSAdditional Listing
13th May 20217:00 amRNSScrip Share Reference Price
30th Apr 20217:00 amRNSInvestor Report at 31 March 2021
21st Apr 202111:06 amRNSDividend Declaration & Scrip Dividend Alternative
19th Apr 20217:00 amRNSNet Asset Value(s)
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSRevolving Credit Facility
22nd Mar 20211:08 pmRNSNew Directorship Notification
12th Mar 20211:29 pmRNSHolding(s) in Company
9th Mar 20214:26 pmRNSDirector/PDMR Shareholding
9th Mar 20219:08 amRNSAdditional Listing and Total Voting Rights
26th Feb 20219:39 amRNSAdditional Listing
11th Feb 20217:00 amRNSScrip Share Reference Price
10th Feb 202112:50 pmRNSDirectorate Change
10th Feb 202112:49 pmRNSResult of AGM
27th Jan 20217:00 amRNSInvestor Report at 31 December 2020
22nd Jan 202111:54 amRNSDividend Declaration & Scrip Dividend Alternative
18th Jan 20217:00 amRNSNet Asset Value(s)
11th Jan 202110:31 amRNSUpdate research from QuotedData
8th Jan 20219:00 amRNSNotice of AGM Circular
31st Dec 20207:00 amRNSTotal Voting Rights
17th Dec 20207:00 amRNSAnnual report and financial statements
7th Dec 202012:37 pmRNSDirector/PDMR Shareholding
7th Dec 20209:13 amRNSAdditional Listing and Total Voting Rights
4th Dec 20207:00 amRNSInvestment Adviser strategic partnership
27th Nov 20207:00 amRNSAdditional Listing
12th Nov 20207:00 amRNSScrip Share Reference Price
30th Oct 20207:00 amRNSInvestor Report as at 30 September 2020
23rd Oct 202011:42 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 202010:41 amRNSDividend Declaration & Script Dividend Alternative
16th Oct 20207:00 amRNSNet Asset Value(s)
12th Oct 20207:00 amRNSGreen Economy Mark
3rd Sep 202012:50 pmRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSAdditional Listing and Total Voting Rights
21st Aug 202012:54 pmRNSAdditional Listing
6th Aug 20207:00 amRNSScrip Share Reference Price
30th Jul 20207:00 amRNSInvestor Report as at 30 June 2020
28th Jul 20201:19 pmRNSNotification of Major Holdings
23rd Jul 202010:42 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jul 20207:00 amRNSNet Asset Value(s)
30th Jun 20207:00 amRNSTotal Voting Rights
10th Jun 20205:35 pmRNSDirector/PDMR Shareholding
10th Jun 202012:04 pmRNSAdditional Listing and Total Voting Rights
3rd Jun 20207:00 amRNSAdditional Listing
1st Jun 20201:48 pmRNSUpdate research from QuotedData
29th May 20207:00 amRNSHalf-yearly Report and Financial Statements 2020
15th May 20207:00 amRNSScrip Share Reference Price
1st May 20207:00 amRNSInvestor Report as at 31 March 2020
24th Apr 202011:16 amRNSDividend Declaration & Scrip Dividend Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.